mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.1 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.1 |